Soren Berg Padkaer

Title: Soren Berg Padkaer: Innovator in Immunology

Introduction

Soren Berg Padkaer is a notable inventor based in Vaerlose, Denmark. He has made significant contributions to the field of immunology, particularly through his innovative research and patenting of human anti-KIR antibodies. His work focuses on enhancing the immune response in subjects, which has important implications for therapeutic applications.

Latest Patents

Soren Berg Padkaer holds a patent for "Human anti-KIR antibodies." This patent describes compositions and methods for regulating an immune response in a subject. More specifically, it details human antibodies that regulate the activity of natural killer (NK) cells, allowing for the potentiation of NK cell cytotoxicity in mammalian subjects. The patent also covers antibodies with antigen-binding properties similar to those of human monoclonal antibodies 1-7F9 or 1-4F1. Additionally, it describes fragments and derivatives of these antibodies, as well as pharmaceutical compositions that include them and their therapeutic uses, particularly in increasing NK cell activity or cytotoxicity in subjects.

Career Highlights

Throughout his career, Soren has worked with prominent companies in the biotechnology sector, including Novo Nordisk A/S and Innate Pharma S.A.S. His experience in these organizations has allowed him to contribute to groundbreaking research and development in immunotherapy.

Collaborations

Soren has collaborated with esteemed colleagues in the field, including Alessandro Moretta and Mariella Della Chiesa. These partnerships have further enriched his research and expanded the impact of his work in immunology.

Conclusion

Soren Berg Padkaer is a distinguished inventor whose work in human anti-KIR antibodies has the potential to revolutionize therapeutic approaches in immunology. His contributions to enhancing NK cell activity are paving the way for new treatments that could significantly improve patient outcomes.